These are 5 biggest stocks in Rakesh Jhunjhunwala’s portfolio, holding values from ₹1,000 cr to ₹11,000 cr

Tata Group-backed Titan is on the high of the pyramid in his portfolio. While Star Health, Metro Brands, and Tata Motors are a few of his current investments. He stayed with Titan and Crisil since 2015. These 5 stocks account for almost 77% of his portfolio wealth.

As per Trendlyne information, the big bull‘s wealth climbed by 25% in lower than two weeks of August to 31,833.77 crore. His wealth was round 25,425.88 crore in June and at a report of 33,753.92 crore in March this 12 months.

From this complete, his shareholding is valued at round 11,086.9 crore in Titan, 7,017.5 crore in Star Health, 3,348.8 crore in Metro Brands, 1,731.1 crore in Tata Motors, and 1,301.9 crore in Crisil as of August 12, 2022.

Since August 13, 2015, the Titan shares emerged as a mutli-bagger with a breath-taking acquire of about 655% up to date. Crisil, nevertheless, soared by almost 71% to date in these years.

Star Health and Metro Brands obtained listed in December final 12 months. The basic well being insurer has dropped by over 23% from its itemizing day, nevertheless, has been on a restoration path since July 2022. Meanwhile, the footwear agency Metro Brands has superior by greater than 76% since its market debut. He invested in Tata Motors in September 2020 quarter, and since then the shares have climbed by a whopping 217.5%, as per information out there on BSE.

Here are Jhunjhunwala’s shareholding particulars in these stocks:

– As of June 30, 2022, the market mogul holds 44,850,970 fairness shares or 5.1% in Titan.

– He holds 100,753,935 fairness shares or 17.5% in Star Health as of June 30, 2022.

– His shareholding stands at 39,153,600 fairness shares or 14.4% by finish of the June 2022 quarter.

– While he holds 36,250,000 fairness shares or 1.1% in Tata Motors by June 2022 quarter finish.

– Jhunjhunwala’s holding in Crisil is round 4,000,000 fairness shares or 1.1% as of June 30, 2022.

Here’s an outline of shares on BSE presently. Analysts have given an optimistic view on a few of these stocks going ahead:

Titan Company:

On BSE, Titan shares are round 2,471.95 apiece as of August 12. The firm’s market cap is 2,19,456.30 crore.

The shares have climbed by not less than 35.55% on Dalal Street in a 12 months. The shares had been round 1,823.55 on August 12 final 12 months.

Analysts Richard Liu, Mehul Desai, and Sumanyu Saraf at JM Financial in their report mentioned, “Titan obtained off to a terrific post-pandemic begin with sturdy metrics throughout all the important thing companies. Sales momentum revived strongly in Jewellery after a weak Mar-Q, with ‘normalised’ development of 23% (3-year CAGR), which is among the greatest seen throughout the consumption classes that we observe. A whole lot of the administration conversations revolved round recruiting newer shoppers into the ecosystem in order to construct a ‘funnel for the future’. Growth, higher combine and resultant costs-leverage drove a good higher profitability vs what we anticipated.”

They also said, “Given the energy throughout segments, administration re-emphasized its bullish total outlook with Jewellery development steerage of two.5x over 5 years, i.e. 20% CAGR over FY22-27E with nearterm margin anticipated at 12-13% vary. Watches appears to have additionally established the next base now, with Wearables turning into an necessary new driver. Same is the case for Eyewear the place current restructuring has yielded sturdy outcomes. We count on the inventory to keep sturdy on the again of this outcome however a >60x NTM PER seems too wealthy an entry level to us.”

JM Financial analysts have set a 12-month target price of 2,620 on Titan.

Star Health and Allied Insurance:

On BSE, Star Health shares are at 696.10 apiece as of August 12. The company’s market cap is around 40,104.98 crore.

Star Health made its market debut on December 10 last year. The company launched its IPO from November 30 to December 3 last year at a price band of 870 to 900 apiece. The IPO witnessed sluggish demand as it did not fully subscribe.

The shares have risen by more than 42% from July this year to date.

HDFC Securities analysts Sahej Mittal, Krishnan ASV, Deepak Shinde, and Neelam Bhatia in their research note said, “Capitalising on an early-mover advantage and significant regulatory arbitrage, STARHEAL is positioned as the largest standalone health insurer (FY22:33% market-share), anchored on an extremely strong and highly productive agency- dominated distribution network and retail-dominated business mix (FY22: ~90% of GDPI). Despite potential regulatory convergence, we believe that STARHEAL has meaningful headroom to pivot to a high-quality franchise, translating into better quality of earnings.”

Further, the analysts mentioned, (*5*)

Metro Brands:

On BSE, the corporate’s shares are round 854.30 apiece. The shares had touched a brand new 52-week excessive of 869 apiece on Friday. The firm’s market cap is round 23,199.04 crore.

Metro Brands shares had been listed on inventory exchanges final 12 months on December 21. The IPO had a value band of 485 to 500 per piece. The 100% e-book constructing subscribed by 3.64 occasions on the first market.

Since its itemizing, Metro Brands shares have skyrocketed by a whopping greater than 76% on BSE. So far, in 2022, the shares have superior by a large over 91.5% making many buyers wealthy together with Jhunjhunwala.

Akhil Parekh Research Analyst and Kevin Shah Research Associate at Centrum in their report mentioned, “Entry into newer geographies, tie-up with international brands (Crocs and Fitflops) coupled with variable cost structure should help company to grow it sales/EBITDA/PAT CAGR at 34/36/47% respectively over FY22-24E. On a low base, we expect volume (no of pairs) to grow at CAGR 25% and ASP at 7% over FY22-24E. We have increased our EPS estimates by 49/36% each for FY23/FY24. We maintain our rating to ADD with target price of Rs821. We continue to value the stock at 48x FY24E.”

Tata Motors:

On BSE, Tata Motors shares are round 477.50 apiece. The firm has a market cap of round 1,58,586.12 crore.

Tata Motors shares have climbed over 56% in a 12 months. The shares had been round 306 on August 12 final 12 months.

Analysts Vivek Kumar and Ronak Mehta at JM Financial in their analysis observe mentioned, “TTMT expects chip shortage to continue with gradual improvement through CY22. Management has guided for a positive EBIT and FCF for FY23 at JLR driven by continued recovery in production, ‘Refocus’ programme and continued efforts towards cost efficiency. Global retail demand remains strong with record high orders and low inventory. Favourable mix, sales recovery and cost saving initiatives are expected to support margins going ahead while focus on debt reduction (target of near debt free by FY24) will aid balance sheet strength. In addition, Tata Motors’ EV portfolio is leading the domestic EV space and by securing strategic investors, it is well poised to build on its initial success. Maintain BUY with Mar’23 SOTP of INR 550(standalone/JLR valued at 10x /2.5x EV/EBIDTA). Continued shortages of semiconductors, lower than expected adoption of EVs and inherent risk in evolving EV technologies are the key risks.”

Meanwhile, Rishi Vora and Eswar Bavineni analysts at Kotak Institutional Equities mentioned, “We have fine-tuned our FY2023-25E consolidated EBITDA estimates. While the near term may remain volatile for JLR due to risk of recession in the EU, we believe the company has done well to improve the structural profitability of the business over the past few years. With the chip situation improving, we believe JLR is well-positioned to benefit given its successful new launches and strong order backlog. Also, we believe the domestic CV cycle recovery will continue as freight rate continues to firm up and fleet utilization levels improve. The company’s successful new launches in domestic ICE PV segment as well as growing consumer demand for EV vehicles remain a bright spot. We maintain BUY rating on the stock with revised FV of Rs500 (from Rs470 earlier) as we roll over to September 2024E (from June 2024E earlier).”

CRISIL:

On BSE, Crisil shares are at 3,261.60 apiece. The firm has a market cap of 23,824.25 crore.

Crisil shares have jumped by greater than 27% in a 12 months. The shares had been round 2,566 apiece final 12 months on August 12.

CRISIL is a number one, agile and progressive world analytics firm pushed by its mission of constructing markets operate higher. It is India’s foremost supplier of scores, information, analysis, analytics, and options. The firm has delivered unbiased opinions, actionable insights, and environment friendly options to over 100,000 clients.

Catch all of the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint.
Download The Mint News App to get Daily Market Updates.

More
Less

Subscribe to Mint Newsletters

* Enter a legitimate e mail

* Thank you for subscribing to our e-newsletter.

.

LEAVE A REPLY

Please enter your comment!
Please enter your name here